Canary Health and Medtronic have teamed-up to expand the reach of Canary's diabetes management suite for pre-diabetes, diabetes and related comorbidities. Under the deal, Medtronic will be a reseller and distributor of Canary Health's programs, including its CDC-recognized Diabetes Prevention Program (DPP). Also, the two parties will be working together to develop additional solutions that leverage Medtronic's devices, services and infrastructure as well as Canary Health's suite of behavior change programs, design expertise, and user engagement experience.
"This new relationship with Canary Health enables us to offer healthcare organizations broader, deeper and more holistic diabetes management solutions that improve clinical outcomes and bend the cost curve as we pursue value-based healthcare models," Annette Brüls, president of Diabetes Service and Solutions at Medtronic, said in a statement.
Beyond diabetes, Medtronic plans to offer Canary Health's other chronic disease self-management programs which address conditions that are commonly associated with diabetes including arthritis, depression, and heart disease, for a more comprehensive and integrated approach to care.
The deal with Medtronic follows Canary Health's recent acquisition of mobile stress management company, bLife, and an exclusive license with Stanford University's Patient Education Research Center for its chronic disease self-management programs, which have achieved the highest criteria for evidence-based programs set by the U.S Department of Health & Human Services and have been proven effective through more than 30 published clinical studies.
There are more than 117 million people in the U.S. suffering from one or more chronic. According to the CDC, health self-management helps people learn techniques to reduce pain and improve function, and to develop skills and confidence to daily manage their conditions.